Back to search
Heart Failure With Preserved Ejection Fraction (HFpEF)
Clinical trial pipeline · Data from ClinicalTrials.gov
See which Heart Failure With Preserved Ejection Fraction (HFpEF) trials may be worth asking aboutClinical trial pipeline · Data from ClinicalTrials.gov
See which Heart Failure With Preserved Ejection Fraction (HFpEF) trials may be worth asking aboutNorth America
Europe
Asia-Pacific
Rest of World
Trials may have sites in multiple countries. Filtering shows any trial with at least one site in the selected country.
The goal of this trial is to to determine whether use of a novel SGLT2 inhibitor, Enavogliflozin 0.3 mg once daily is superior to placebo, when added to standar…
ELEVATE-HFpEF is a prospective, randomized, controlled, double-blinded, multi-center, global, interventional pivotal study evaluating the safety and efficacy of…
The AIM HIGHer Clinical Trial will evaluate the safety and efficacy of Cardiac Contractility Modulation (CCM) therapy in patients with heart failure with LVEF ≥…
Subjects undergo a gadolinium-based CMR followed by an iron infusion and then a repeat CMR in 72 hours
What is HFpEF? In heart failure with preserved ejection fraction (HFpEF), the heart pumps well but struggles to relax and fill with blood between beats. This ra…
This study will test whether pharmacologic agents that increase perfusion \[Potassium Nitrate (KNO3)\], with and without additional supplements that may improve…
The main objective of this study is to determine the clinical efficacy of metformin versus placebo and the therapeutic response with regards to functional capac…
The clinical benefits of the dual Sodium-Glucose cotransporter (SGLT) 1 and 2-inhibition have recently been reported in two clinical trials. The SOLOIST reporte…